Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 3/20 | 0.66 |
| ▸ | KCNA3 | P22001 | 2/20 | 0.66 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.56 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.56 |
| ▸ | HTR2A | P28223 | 2/20 | 0.56 |
| ▸ | HTR2C | P28335 | 2/20 | 0.56 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.56 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.56 |
| ▸ | CCKBR | P32239 | 2/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.56 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.56 |
| ▸ | GMNN | O75496 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7796676 | 0.83 | CYP11B1 (0.46) | KCNN4KCNA3CYP19A1OPRK1KCNH2 | |
| SCHEMBL41130 | 0.79 | KCNN4 (1.00) | KCNN4KCNA3CYP19A1OPRK1KCNH2 | |
| SCHEMBL29499525 | 0.79 | KCNN4 (1.00) | KCNN4KCNA3CYP19A1OPRK1KCNH2 | |
| SCHEMBL2360873 | 0.78 | KCNN4 (0.57) | KCNN4KCNA3CYP19A1OPRK1KCNH2 | |
| SCHEMBL2388992 | 0.74 | KCNN4 (0.60) | KCNN4KCNA3CYP19A1OPRK1KCNH2 | |
| SCHEMBL5479925 | 0.73 | CYP19A1 (0.66) | KCNN4KCNA3CYP19A1OPRK1KCNH2 | |
| Clotrimazole SCHEMBL29358270 | 0.72 | CYP19A1 (1.00) | KCNN4KCNA3CYP19A1OPRK1KCNH2 | |
| Clotrimazole SCHEMBL1062253 | 0.72 | CYP19A1 (1.00) | KCNN4KCNA3CYP19A1OPRK1KCNH2 | |
| SCHEMBL332191 | 0.72 | KCNN4 (0.61) | KCNN4KCNA3CYP19A1OPRK1KCNH2 | |
| SCHEMBL9720736 | 0.72 | CYP19A1 (0.94) | KCNN4KCNA3CYP19A1OPRK1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010011137-A1 | Use of triphenylmethyl-1,2,3-triazoles | URBAHNS KLAUS (DE) | 2001-08-02 | — | — | US | claimed |
| US-20010011137-A1 | Use of triphenylmethyl-1,2,3-triazoles | URBAHNS KLAUS (DE) | 2001-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010011137-A1 | Use of triphenylmethyl-1,2,3-triazoles | PNMT, NLN, TPMT | KCNN4 2263/4885KCNA3 921/4885CYP19A1 1909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.